BioWednesday Cambridge: How do Investors and Entrepreneurs Evaluate Intellectual Property?

****Registration for this event is now closed, if you wish to register please contact laurabacchus@onenucleus.com****

In collaboration with 

An effective IP strategy is key for helping biotech companies attract potential investors. Our panel will discuss how investors and entrepreneurs evaluate IP for company creation, fund raising and transactions, including in cases where patent protection may not always be possible. We will explore how companies can put themselves into the best possible position for successful IP due diligence. We hope that you can join us afterwards for networking and refreshments.

17.30 - Arrival and Registration

18.00 - Panel:How do Investors and Entrepreneurs Evaluate Intellectual Property?

Panel  
Edward Rainsford, Senior Associate, Appleyard Lees (Moderator)
Alison McGhee, Assistant General Counsel, IP, AstraZeneca
Iain Thomas, Head of Life Sciences, Cambridge Enterprise
Mike Romanos, Associate Dean for Enterprise, Faculty of Medicine, Imperial College
Anne Horgan, Partner, Cambridge Innovation Capital

19.00 - Networking and Light Refreshments

20.00 - Close

Prices

One Nucleus members: Free
Non-Members: £50 + VAT
Academics: please contact alicia@onenucleus.com